![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Parkinson's Disease |
Free Subscription
2 BMC Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Parkinson's Disease is free of charge.
What web-based information is available for people with Parkinson's disease
interested in aquatic physiotherapy? A social listening study.
BMC Neurol. 2022;22:170.
PubMed
Abstract available
Clinical uses of Bupropion in patients with Parkinson's disease and comorbid
depressive or neuropsychiatric symptoms: a scoping review.
BMC Neurol. 2022;22:169.
PubMed
Abstract available
Hydroxychloroquine attenuated motor impairment and oxidative stress in a rat
6-hydroxydopamine model of Parkinson's disease.
Int J Neurosci. 2022 May 6:1-13. doi: 10.1080/00207454.2022.2074848.
PubMed
Abstract available
Adaptive changes in striatal projection neurons explain the long duration
response and the emergence of dyskinesias in patients with Parkinson's disease.
J Neural Transm (Vienna). 2022 May 10. pii: 10.1007/s00702-022-02510.
PubMed
Abstract available
A brief history of brain iron accumulation in Parkinson disease and related
disorders.
J Neural Transm (Vienna). 2022 May 9. pii: 10.1007/s00702-022-02505.
PubMed
Abstract available
Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review.
Mov Disord. 2022 May 6. doi: 10.1002/mds.29047.
PubMed
Abstract available
Assessment of GGC Repeat Expansion in GIPC1 in Patients with Parkinson's Disease.
Mov Disord. 2022 May 6. doi: 10.1002/mds.29041.
PubMed
Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease.
Mov Disord. 2022 May 6. doi: 10.1002/mds.29043.
PubMed
Abstract available
Dopaminergic Positron Emission Tomography Imaging in the Alpha-Synuclein
Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease.
Mov Disord. 2022 May 7. doi: 10.1002/mds.29051.
PubMed
Abstract available
TDP-43 Proteinopathy Presenting with Typical Symptoms of Parkinson's Disease.
Mov Disord. 2022 May 9. doi: 10.1002/mds.29048.
PubMed
Abstract available
Parkinson's disease in the single-cell era.
Nat Neurosci. 2022;25:536-538.
PubMed
Single-cell genomic profiling of human dopamine neurons identifies a population
that selectively degenerates in Parkinson's disease.
Nat Neurosci. 2022;25:588-595.
PubMed
Abstract available
Evidence for immune system alterations in peripheral biological fluids in
Parkinson's disease.
Neurobiol Dis. 2022 May 2:105744. doi: 10.1016/j.nbd.2022.105744.
PubMed
Abstract available
The Anti-Parkinson Potential of Gingko biloba-Supplement Mitigates
Cortico-Cerebellar Degeneration and Neuropathobiological Alterations via
Inflammatory and Apoptotic Mediators in Mice.
Neurochem Res. 2022 May 9. pii: 10.1007/s11064-022-03600.
PubMed
Abstract available
Refractory status epilepticus due to vitamin B6 deficit in a Parkinson's disease
patient in treatment with levodopa/carbidopa intestinal gel.
Neurologia (Engl Ed). 2022 May 5. pii: S2173-5808(22)00047.
PubMed
Cognitive and affective disturbances in patients with Parkinson's disease:
perspectives for classifying of motor/neuropsychiatric subtypes.
Neurosci Lett. 2022 May 6:136675. doi: 10.1016/j.neulet.2022.136675.
PubMed
Abstract available
Noradrenergic deficits contribute to apathy in Parkinson's disease through the
precision of expected outcomes.
PLoS Comput Biol. 2022;18:e1010079.
PubMed
Abstract available
Molecular imaging in Parkinsonism: The essential for clinical practice and future
perspectives.
Rev Neurol (Paris). 2022 May 5. pii: S0035-3787(22)00547.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by